GLPwatch
Soliqua for Depression
lixisenatide · Investigational / off-label
Last updated 2026-05-28 15:46 UTCSoliqua (lixisenatide) is not FDA-approved for depression, and any use for this condition is off-label or investigational. Research in mice suggests lixisenatide may influence neurogenesis and reduce depression-like symptoms, but these findings have not been confirmed in humans.
AI summary of the sources below.
| Drug | Soliqua (lixisenatide) |
|---|---|
| Condition | Depression |
| Approval status | Investigational / off-label |
| Research papers | 2 |
Soliqua is not FDA-approved for depression; the research below reflects investigational or off-label study only.